Clinical trial
Food Effects on the Relative Bioavailability of a Risedronate 20 mg Delayed-release [DR] Tablet and to Compare the 20 mg DR Tablet to 35 mg DR and 35 mg Immediate-release Tablets
NCT00717145 is registered in ClinicalTrials.gov with Warner Chilcott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Food Effects on the Relative Bioavailability of a Risedronate 20 mg Delayed-release [DR] Tablet and to Compare the 20 mg DR Tablet to 35 mg DR and 35 mg Immediate-release Tablets
- Lead sponsor
- Warner Chilcott
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2008
- Completion date
- September 30, 2008
- Enrollment
- 94 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
non-lactating, postmenopausal, surgically sterile